XBMEX: BlackRock Health Sciences

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

XBMEX BlackRock Health Sciences

  • Fund
  • XBMEX
  • Price as of: Jan 16, 2020
  • $41.81
    + $0.25 + 0.60%

Profile

XBMEX - Profile

Vitals

  • YTD Return 1.5%
  • 3 Yr Annualized Return 9.4%
  • 5 Yr Annualized Return 1.1%
  • Net Assets $386 M
  • Holdings in Top 10 40.4%

52 WEEK LOW AND HIGH

$41.81
$35.21
$41.81

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.11%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 37.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return 1.5%
  • 3 Yr Annualized Total Return 9.4%
  • 5 Yr Annualized Total Return 1.1%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.19%
DIVIDENDS
  • Dividend Yield 1.4%
  • Dividend Distribution Frequency Monthly

Fund Details

  • Legal Name
    BlackRock Health Sciences Trust
  • Fund Family Name
    BlackRock
  • Inception Date
    Mar 28, 2005
  • Shares Outstanding
    9380449
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description

N/A


Get Updates About XBMEX

Sign up for Advisor Access to receive email updates about XBMEX competitors, news, CE accredited webcasts and more.

Please Enter Your Email
Please Select Your Advisor Type

Categories

Fund Company Quick Screens

XBMEX - Fund Company Quick Screens


Performance

XBMEX - Performance

Return Ranking - Trailing

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.5% 0.0% 6.2% 84.50%
1 Yr 13.2% 2.9% 41.8% 65.55%
3 Yr 9.4%* -9.3% 27.9% 49.54%
5 Yr 1.1%* -9.8% 14.7% 48.08%
10 Yr 4.1%* -2.7% 18.8% 76.14%

* Annualized

Return Ranking - Calendar

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
2019 14.8% 5.7% 55.4% 77.31%
2018 0.5% -25.3% 21.5% 11.71%
2017 14.1% -10.8% 43.9% 56.88%
2016 -13.5% -31.6% 6.9% 41.51%
2015 -6.3% -20.4% 13.8% 73.79%

Total Return Ranking - Trailing

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.5% 0.0% 6.2% 84.50%
1 Yr 13.2% 2.9% 41.8% 65.55%
3 Yr 9.4%* -9.3% 31.1% 60.55%
5 Yr 1.1%* -9.8% 16.6% 68.27%
10 Yr 4.1%* -2.7% 18.8% 87.50%

* Annualized

Total Return Ranking - Calendar

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
2019 14.8% 5.7% 55.4% 77.31%
2018 0.5% -25.3% 22.2% 19.82%
2017 14.1% -10.8% 45.8% 69.72%
2016 -13.5% -26.4% 8.7% 56.60%
2015 -6.3% -16.6% 15.2% 79.61%

NAV & Total Return History


Holdings

XBMEX - Holdings

Concentration Analysis

XBMEX Category Low Category High XBMEX % Rank
Net Assets 386 M 3.58 M 48.1 B 65.35%
Number of Holdings 314 18 399 1.55%
Net Assets in Top 10 159 M 71.5 K 17.4 B 64.34%
Weighting of Top 10 40.40% 21.3% 75.3% 48.06%

Top 10 Holdings

  1. UnitedHealth Group Inc 7.12%
  2. Abbott Laboratories 6.36%
  3. Boston Scientific Corp 4.04%
  4. Thermo Fisher Scientific Inc 3.76%
  5. Stryker Corp 3.74%
  6. Medtronic PLC 3.66%
  7. Merck & Co Inc 3.24%
  8. Edwards Lifesciences Corp 2.87%
  9. Amgen Inc 2.83%
  10. Zoetis Inc Class A 2.77%

Asset Allocation

Weighting Return Low Return High XBMEX % Rank
Stocks
94.18% 48.12% 103.54% 95.35%
Cash
5.25% 0.00% 51.88% 6.20%
Other
0.57% -27.41% 5.17% 21.71%
Preferred Stocks
0.00% 0.00% 1.08% 51.94%
Convertible Bonds
0.00% 0.00% 1.54% 46.51%
Bonds
0.00% 0.00% 20.60% 43.41%

Stock Sector Breakdown

Weighting Return Low Return High XBMEX % Rank
Healthcare
98.26% 58.44% 100.00% 75.97%
Technology
1.22% 0.00% 16.36% 6.98%
Basic Materials
0.52% 0.00% 2.02% 13.95%
Utilities
0.00% 0.00% 0.00% 39.53%
Real Estate
0.00% 0.00% 5.84% 44.96%
Industrials
0.00% 0.00% 2.40% 46.51%
Financial Services
0.00% 0.00% 6.09% 49.61%
Energy
0.00% 0.00% 0.43% 42.64%
Communication Services
0.00% 0.00% 1.02% 43.41%
Consumer Defense
0.00% 0.00% 36.20% 44.96%
Consumer Cyclical
0.00% 0.00% 10.50% 44.19%

Stock Geographic Breakdown

Weighting Return Low Return High XBMEX % Rank
US
84.92% 48.12% 99.93% 41.09%
Non US
9.26% 0.00% 39.36% 77.52%

Expenses

XBMEX - Expenses

Operational Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.11% 0.10% 9.84% 62.20%
Management Fee 0.19% 0.09% 1.30% 1.55%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 37.00% 0.00% 341.00% 54.03%

Distributions

XBMEX - Distributions

Dividend Yield Analysis

XBMEX Category Low Category High XBMEX % Rank
Dividend Yield 1.44% 0.00% 5.21% 4.65%

Dividend Distribution Analysis

XBMEX Category Low Category High Category Mod
Dividend Distribution Frequency Monthly Annually Annually Annually

Net Income Ratio Analysis

XBMEX Category Low Category High XBMEX % Rank
Net Income Ratio 0.19% -2.24% 2.12% 28.35%

Capital Gain Distribution Analysis

XBMEX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

XBMEX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

Mar 28, 2005

14.77

14.8%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Kyle McClements


Start Date

Tenure

Tenure Rank

Jun 20, 2012

7.53

7.5%

McClements joined BlackRock following the merger with SSRM in 2005. Prior to joining BlackRock, he was vice president of SSRM's Quantitative Strategies Group where one of his responsibilities was implementing different option strategies on various equity accounts since 2004. Prior to joining SSRM, McClements was a vice president at Deutsche Asset Management where he was a derivative, program and FX trader. From 1998 to 2001, he was also a portfolio manager for the ProEquity Fund Series.

Christopher Accettella


Start Date

Tenure

Tenure Rank

Sep 14, 2012

7.3

7.3%

Christopher M. Accettella, Director, is a member of the Fundamental Equity platform within BlackRock's Portfolio Management Group. He is a trader responsible for executing equity derivatives and options trades. Prior to joining BlackRock in 2005, Mr. Accettella was an institutional sales trader with American Technology Research. From 2001 to 2003, he was with Deutsche Asset Management where he was responsible for derivatives and program trading. Prior to that, he was a senior associate in the Pacific Basin Equity Group at Scudder Investments Singapore Limited. Mr. Accettella began his investment career in 1997 as a portfolio analyst in the European Equity group of Scudder Kemper Investments, Inc. Mr. Accettella earned a BA degree in economics and Asian studies from Colgate University in 1997.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.59 22.31 9.83 19.68